Article
Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells
28 Mar 2006
Abstract excerpt
PTX (Paclitaxel) is an antimitotic agent used in the treatment of a number of major solid tumours, particularly in breast and ovarian cancer. This study was undertaken to gain insight into the molecular alterations producing PTX resistance in ovarian cancer. PTX treatment is able to induce apoptosis in the human ovarian carcinoma cell line, CABA I. PTX-induced apoptosis in CABA I cells was accompanied by an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
